Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Michael J. Weickert
Observed names:
M J Weickert,
M. Weickert,
M.J. Weickert,
Michael J Weickert,
Michael Weickert,
Weickert, Michael J.
show all 6
Observed institutions:
Northern Illinois University,
National Institutes of Health,
University of Wisconsin–Madison,
University of Colorado Boulder,
National Cancer Institute,
Baxter (United States)
show all 6
OpenAlex ID:
A5087757111
A family of bacterial regulators homologous to Gal and Lac repressors.
1992
·
M.J. Weickert
, S Adhya
·
Journal of Biological Chemistry
·
361
Site-directed mutagenesis of a catabolite repression operator sequence in Bacillus subtilis.
1990
·
M J Weickert
, G H Chambliss
·
Proceedings of the National Academy of Sciences
·
291
Optimization of heterologous protein production in Escherichia coli
1996
·
Michael J Weickert
, Daniel H Doherty
, et al.
·
Current Opinion in Biotechnology
·
156
The galactose regulon of Escherichia coli
1993
·
Michael J. Weickert
, Sankar Adhya
·
Molecular Microbiology
·
153
Catabolite repression-resistant mutations of the Bacillus subtilis alpha-amylase promoter affect transcription levels and are in an operator-like sequence
1987
·
Wayne L. Nicholson
, Yong-Keun Park
, et al.
·
Journal of Molecular Biology
·
95
Incorporation of Norvaline at Leucine Positions in Recombinant Human Hemoglobin Expressed in Escherichia coli
1997
·
Izydor Apostol
, Joseph Levine
, et al.
·
Journal of Biological Chemistry
·
92
Control of transcription of gal repressor and isorepressor genes in Escherichia coli
1993
·
M J Weickert
, S Adhya
·
Journal of Bacteriology
·
64
Using chromosomal lacIQ1 to control expression of genes on high-copy-number plasmids in Escherichia coli1Published in conjunction with A Wisconsin Gathering Honoring Waclaw Szybalski on the occasion of his 75th year and 20years of Editorship-in-Chief of Gene, 10–11 August 1997, University of Wisconsin, Madison, WI, USA.1
1998
·
Christopher B Glascock
, Michael J. Weickert
·
Gene
·
61
Stabilization of apoglobin by low temperature increases yield of soluble recombinant hemoglobin in Escherichia coli
1997
·
M J Weickert
, M Pagratis
, et al.
·
Applied and Environmental Microbiology
·
57
PDF
Isorepressor of the gal regulon in Escherichia coli
1992
·
Michael J. Weickert
, Sankar Adhya
·
Journal of Molecular Biology
·
52
A Mutation That Improves Soluble Recombinant Hemoglobin Accumulation in Escherichia coli in Heme Excess
1999
·
Michael J. Weickert
, Maria Pagratis
, et al.
·
Applied and Environmental Microbiology
·
48
Analysis of Resident and Transformant Plasmids in Bacillus Megaterium
1984
·
Mark K. Kieselburg
, Michael Weickert
, et al.
·
Nature Biotechnology
·
38
Genetic analysis of the promoter region of the Bacillus subtilis alpha-amylase gene
1989
·
M J Weickert
, G H Chambliss
·
Journal of Bacteriology
·
29
Turnover of Recombinant Human Hemoglobin inEscherichia coliOccurs Rapidly for Insoluble and Slowly for Soluble Globin
1997
·
Michael J. Weickert
, Shawn R. Curry
·
Archives of Biochemistry and Biophysics
·
27
Production of toxin by Clostridium botulinum type A strains cured by plasmids
1986
·
M J Weickert
, G H Chambliss
, et al.
·
Applied and Environmental Microbiology
·
27
A first-in-human phase I trial of daily oral zelenirstat, a N-myristoyltransferase inhibitor, in patients with advanced solid tumors and relapsed/refractory B-cell lymphomas
2024
·
Randeep Sangha
, Rahima Jamal
, et al.
·
Investigational New Drugs
·
23
Identification of a Nickel(II) Binding Site on Hemoglobin Which Confers Susceptibility to Oxidative Deamination and Intramolecular Cross-linking
1998
·
Joseph Levine
, Michael Weickert
, et al.
·
Journal of Biological Chemistry
·
22
PDF
High-Fidelity Translation of Recombinant Human Hemoglobin in Escherichia coli
1998
·
Michael J. Weickert
, Izydor Apostol
·
Applied and Environmental Microbiology
·
18
PDF
A mutation defining ultrainduction of the Escherichia coli gal operon
1991
·
A Golding
, M J Weickert
, et al.
·
Journal of Bacteriology
·
11
Initial Characterization and Toxicology of an Nmt Inhibitor in Development for Hematologic Malignancies
2019
·
Michael Weickert
, John Dillberger
, et al.
·
Blood
·
6
A first-in-human, open-label, phase I trial of daily oral PCLX-001, an NMT inhibitor, in patients with relapsed/refractory B-cell lymphomas and advanced solid tumors.
2023
·
Randeep S. Sangha
, Rahima Jamal
, et al.
·
Journal of Clinical Oncology
·
5
Negative Control of Amylase Synthesis: Mutations Which Eliminate Catabolite Repression or Temporal Turn-off
1990
·
M.J. Weickert
, L. Larson
, et al.
·
Genetics and Biotechnology of Bacilli
·
4
Locations and orientations on the Escherichia coli physical map of the mgl operon and galS, a new locus for galactose ultrainduction
1991
·
M J Weickert
, R W Hogg
, et al.
·
Journal of Bacteriology
·
3
Zelenirstat Nmt Inhibitor in Patients with Relapsed/Refractory B-Cell Lymphoma and Acute Myelogenous Leukemia: Mechanistic Insights and Clinical Outcomes
2024
·
Randeep Sangha
, John Kuruvilla
, et al.
·
Blood
·
2
PDF
Final results of a first-in-human phase I dose escalation trial of daily oral zelenirstat, a n-myristoyltransferase inhibitor, in patients with advanced solid tumors and relapsed/refractory B-cell lymphomas.
2024
·
Randeep S. Sangha
, Rahima Jamal
, et al.
·
Journal of Clinical Oncology
·
2
Show more works
View as search
Works count:
36
Citation count:
1,653
H-index:
18
I10-index:
19
Year
Topic
Type
